
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injecti... Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -1.17 | -3.90130043348 | 29.99 | 30.555 | 27.05 | 778657 | 28.98024583 | CS |
4 | -7.38 | -20.3867403315 | 36.2 | 36.475 | 25.99 | 1127317 | 28.98730235 | CS |
12 | -15.22 | -34.5594913715 | 44.04 | 45.27 | 25.99 | 850689 | 33.94448127 | CS |
26 | -9.6 | -24.9869859448 | 38.42 | 51.61 | 25.99 | 793155 | 39.27026772 | CS |
52 | -15.08 | -34.3507972665 | 43.9 | 51.61 | 25.99 | 757890 | 39.59684612 | CS |
156 | 6.01 | 26.3480929417 | 22.81 | 51.61 | 5.2 | 583106 | 27.22521687 | CS |
260 | 17.41 | 152.585451358 | 11.41 | 51.61 | 5.2 | 472653 | 27.00063038 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.